Fogarty International Scholar and the National Cancer Institute visiting scholar in California at Stanford University, is. This work led by Novartis to the development of Gleevec. THE 2005 WOLF FOUNDATION PRIZE has decided unanimously that the 2005 Wolf Prize. Two recipients of the 2005 Wolf Prize have contributed independently in the effect and biology to an understanding of the tyrosine kinase signaling pathways. Anthony R. Hunter s contributions discovered that tyrosine phosphorylation.